Evaluating predictive markers for viral rebound and safety assessment in blood and lumbar fluid during HIV-1 treatment interruption

BACKGROUND: Validated biomarkers to evaluate HIV-1 cure strategies are currently lacking, therefore requiring analytical treatment interruption (ATI) in study participants. Little is known about the safety of ATI and its long-term impact on patient health. OBJECTIVES: ATI safety was assessed and pot...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Antimicrob Chemother
Main Authors: De Scheerder, Marie-Angélique, Van Hecke, Clarissa, Zetterberg, Henrik, Fuchs, Dietmar, De Langhe, Nele, Rutsaert, Sofie, Vrancken, Bram, Trypsteen, Wim, Noppe, Ytse, Van Der Gucht, Bea, Pelgrom, Jolanda, Van Wanzeele, Filip, Palmer, Sarah, Lemey, Philippe, Gisslén, Magnus, Vandekerckhove, Linos
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2020
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7869780/
https://ncbi.nlm.nih.gov/pubmed/32053203
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkaa003
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares